We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Serial Measurement of Serum Antimullerian Hormone in Women Undergoing Laparoscopic Cystectomy of Endometrioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01065168
Recruitment Status : Unknown
Verified January 2009 by Mahidol University.
Recruitment status was:  Active, not recruiting
First Posted : February 9, 2010
Last Update Posted : February 17, 2010
Sponsor:
Information provided by:

Study Description
Brief Summary:
The purpose of this trial is to study ovarian reserve after laparoscopic endometrioma cystectomy by measuring antimullerian hormone. The measurements were measured before the surgery and one week and three months after the surgery.

Condition or disease
Endometriosis

Detailed Description:
Antimullerian hormone will be obtained in patients with ovarian endometrioma before laparoscopic cystectomy is done. The measurements were compared with antimullerian hormone after one week and three months after the surgery. Forty three patients will be included in this study.

Study Design

Study Type : Observational
Actual Enrollment : 43 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Serial Measurement of Serum Antimullerian Hormone in Women Undergoing Laparoscopic Cystectomy of Endometrioma
Study Start Date : January 2009
Estimated Primary Completion Date : January 2010
Estimated Study Completion Date : March 2010

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Group/Cohort
endometrioma
ovarian endometrioma undergoing cystectomy


Outcome Measures

Primary Outcome Measures :
  1. Ovarian reserve before and after ovarian endometrioma cystectomy. [ Time Frame: one week and three months ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
ovarian endometrioma performed laparoscopic cystectomy
Criteria

Inclusion Criteria:

  • 20-40 years
  • ovarian endometrioma > or = 3 cms
  • laparoscopic cystectomy treatment

Exclusion Criteria:

  • previous ovarian surgery
  • other ovarian pathology
  • previous drugs or hormonal treatment for endometrioma
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01065168


Sponsors and Collaborators
Mahidol University
Investigators
Principal Investigator: Singpetch Suksompong, Doctor Mahidol University
More Information

Responsible Party: Singpetch Suksompong, Mahidol University
ClinicalTrials.gov Identifier: NCT01065168     History of Changes
Other Study ID Numbers: si637/2008
First Posted: February 9, 2010    Key Record Dates
Last Update Posted: February 17, 2010
Last Verified: January 2009

Keywords provided by Mahidol University:
endometriosis
endometrioma
antimullerian hormone
cystectomy

Additional relevant MeSH terms:
Endometriosis
Genital Diseases, Female
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs